Dalton to manufacture Arch's peptide drug candidate ahead of Ph I trial
The Canadian CDMO Dalton Pharma Services will manufacture Arch Biopartners' drug candidate for use in Phase I clinical trials.
Archives for August 22, 2018
Boehringer Ingelheim CDMO providing CMC services for Ph Ib/III trial of cancer antibody
Boehringer Ingelheim’s China-based CDMO is providing clinical trial materials for CANbridge Life Sciences' Phase Ib/III study of its drug candidate intended to treat esophageal cancer.
China dismisses top officials over sub-par vaccines
A number of officials related to the Changsheng Biotechnology vaccine scandal have been relieved of their positions by China’s government.
EpiPen expiry extension gives Pfizer four months to grow supply
The US FDA has granted expiration date extensions for specific lots of Mylan’s EpiPen auto-injectors, as manufacturer Pfizer works to stabilise supply.
Nebraska obtained lethal injection from unauthorised source, says Fresenius Group
The State of Nebraska has carried out an execution using drugs procured from an illegitimate source, claims Fresenius Kabi.
Otsuka taps TrialAssure for clinical trial pipeline disclosure reporting system
Otsuka Pharmaceutical is partnering with TrialAssure to establish a clinical trial transparency management system in its drug development pipeline.
Datatrak receives $8m from TabaFund to advance eClinical solutions
The $8m from its long-term investor TabaFund will be used to expand Datatrak’s sales and e-clinical technologies for the clinical research industry.